Manage episode 295258847 series 2793637
CytImmune Sciences is an emerging leader in cancer nanomedicine. It is a platform company with products of its own in development. CEO Saba explains the technology and why he is confident it will ultimately help patients. The company has a Phase II development collaboration with the National Cancer Institute, and is scaling up its manufacturing to be ready.